Inhibition of food intake in response to intestinal lipid is mediated by cholecystokinin in humans

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 277, Issue 6 46-6, 1999, Pages

  Matzinger, Daniel ^a   Gutzwiller, Jean Pierre ^a   Drewe, Juergen ^a   Orban, Amar ^a   Engel, Reto ^a   D'Amato, Massimo ^b   Rovati, Lucio ^b   Beglinger, Christoph ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Rotta Research Laboratorium   (Italy)

Author keywords

Appetite; Gastric distension; Intraduodenal fat

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; FAT; LIPID; LOXIGLUMIDE; SODIUM CHLORIDE;

ADULT; ARTICLE; CALORIC INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; INHIBITION KINETICS; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SATIETY; STOMACH DISTENSION; STOMACH EMPTYING;

EID: 0033378595     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1999.277.6.r1718     Document Type: Article

References (50)

1. Atkinson, R. L., E. L. Brent, B. S. Wagner, and J. H. Whipple. Energy balance and regulation of body weight after intestinal bypass surgery in rats. Am. J. Physiol. 245 (Regulatory Integrative Comp. Physiol. 14): R658-R663, 1983.
2. Atkinson, R. L., J. H. Whipple, S. H. Atkinson, and C. C. Stewart. The role of the small bowel in regulating food intake in rats. Am. J. Physiol. 242 (Regulatory Integrative Comp. Physiol. 11): R429-R433, 1982.
3. Bado, A., S. Levasseur, S. Attoub, S. Kermorgant, J. P. Laigneau, M. N. Bortoluzzi, L. Moizo, T. Lehy, M. Guerre-Millo, Y. Le Marchand-Brustel, and M. J. Lewin. The stomach is a source of leptin. Nature 394: 790-793, 1998.
4. Baile, C. A., C. L. McLaughlin, and M. A. Della-Ferra. Role of cholecystokinin and opioid peptides in control of food intake. Physiol. Rev. 66: 172-234, 1986.
5. Barrachina, M. D., V. Martinez, J. Y. Wei, and Y. Tache. Leptin-induced decrease in food intake is not associated with changes in gastric emptying in lean mice. Am. J. Physiol. 272 (Regulatory Integrative Comp. Physiol. 41): R1007-R1011, 1997.
6. Douglas, B. R., J. B. M. J. Jansen, A. J. L. de Jong, and C. B. H. W. Lamers. Effect of various triglycerides on plasma cholecystokinin levels in rats. J. Nutr. 120: 686-690, 1990.
7. Douglas, B. R., R. A. Woutersen, J. B. M. J. Jansen, A. J. L. de Jong, and C. B. H. W. Lamers. The influence of different nutrients on plasma cholecystokinin levels in rats. Experientia 44: 21-23, 1988.
8. Drewe, J., A. Gadient, L. C. Rovati, and C. Beglinger. Role of circulating cholecystokinin in control of fat-induced inhibition of food intake in humans. Gastroenterology 102: 1654-1659, 1992.
9. Feinle, C., M. D'Amato, and N. W. Read. Cholecystokinin-A receptors modulate gastric sensory and motor responses to gastric distension and duodenal lipid. Gastroenterology 110: 1379-1385, 1996.
10. Figlewicz, D. P., A. J. Sipols, D. Porte, S. C. J. Woods, and R. A. Liddle. Intraventricular CCK inhibits food intake and gastric emptying in the baboon. Am. J. Physiol. 256 (Regulatory Integrative Comp. Physiol. 25): R1313-R1317, 1989.
11. Foltin, R. W., and T. H. Moran. Food intake in baboons: effect of a long-acting cholecystokinin analog. Appetite 12: 145-152, 1989.
12. Gibbs, J., J. D. Falasco, and P. R. McHugh. Cholecystokinin decreases food intake in rhesus monkeys. Am. J. Physiol. 230: 15-18, 1976.
13. Gibbs, J., R. C. Young, and G. P. Smith. Cholecystokinin decreases food intake in rats. J. Comp. Physiol. Psychol. 84: 488-495, 1973.
14. Gibbs, J., R. C. Young, and G. P. Smith. Cholecystokinin elicits satiety in rats with open gastric fistulas. Nature 245: 323-325, 1973.
15. Green, G. M., S. Taguchi, J. Friestman, W. Y. Chey, and R. A. Liddle. Plasma secretin: CCK and pancretic secretion in response to dietary fat in the rat. Am. J. Physiol. 256 (Gastrointest. Liver Physiol. 19): G1016-G1021, 1989.
16. Greenberg, D., N. J. Torres, G. P. Smith, and J. Gibbs. The satiating effects of fats is attenuated by the cholecystokinin antagonist lorglumide. Ann. NY Acad. Sci. 575: 517-520, 1989.
17. Gregory, P. C., M. McFadyen, and D. V. Rayner. Duodenal infusion of fat, cholecystokinin secretion and satiety in the pig. Physiol. Behav. 45: 1021-1024, 1989.
18. Hashimura, E., F. Shimizu, T. Nishino, K. Imagawa, K. Tateishi, and T. Hamaoka. Production of rabbit antibody specific for aminoterminal residues of cholecystokinin octapeptide (CCK-8) by selective suppression of cross-reactive antibody response. J. Immunol. Methods 55: 375-387, 1982.
19. Hildebrand, P., C. Beglinger, K. Gyr, J. B. M. J. Jansen, L. C. Rovati, M. Zuercher, C. B. H. W. Lamers, I. Setnikar, and G. A. Stalder. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man. J. Clin. Invest. 85: 640-646, 1990.
20. Kaplan, L. M. Leptin, obesity, and liver disease. Gastroenterology 115: 997-1001, 1998.
21. Kissileff, H. R., F. X. Pi-Sunyer, J. Thornton, and G. P. Smith. C-terminal octapeptide of cholecystokinin decreases food intake in man. Am. J. Clin. Nutr. 34: 154-160, 1981.
22. Liddle, R. A., I. D. Goldfine, M. S. Rosen, R. A. Taplitz, and J. A. Williams. Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J. Clin. Invest. 75: 1144-1152, 1985.
23. Liddle, R. A., I. D. Goldfine, and J. A. Williams. Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol. Gastroenterology 87: 542-549, 1984.
24. Liddle, R. A., E. T. Morita, C. K. Conrad, and J. A. Williams. Regulation of gastric emptying in humans by cholecystokinin. J. Clin. Invest. 77: 992-996, 1986.
25. Lieverse, R. J., J. B. M. J. Jansen, A. A. M. Masclee, and C. B. H. W. Lamers. Satiety effects of cholecystokinin in humans. Gastroenterology 106: 1451-1454, 1994.
26. Lieverse, R. J., J. B. M. J. Jansen, A. A. M. Masclee, L. C. Rovati, and C. B. H. W. Lamers. Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide. Gut 35: 501-505, 1994.
27. Lieverse, R. J., J. B. M. J. Jansen, A. van de Zwan, L. Samson, A. A. M. Masclee, and C. B. H. W. Lamers. Effects of a physiological dose of cholecystokinin on food intake and postprandial satiation in man. Regul. Pept. 43: 83-89, 1993.
28. Lieverse, R. J., A. A. Masclee, J. B. Jansen, L. C. Rovati, and C. B. Lamers. Satiety effects of the type A CCK receptor antagonist loxiglumide in lean and obese women. Biol. Psychiatry 37: 331-335, 1995.
29. Lilja, P. I., I. Wiener, G. M. Inoue, G. M. Fried, J. R. Greely, and J. C. Thompson. Release of cholecystokinin in response to food and intraduodenal fat in pigs, dogs and man. Surg. Gynecol. Obstet. 159: 557-561, 1984.
30. McHugh, P. R., and T. H. Moran. The stomach, cholecystokinin, and satiety. Federation Proc. 45: 1384-1390, 1986.
31. Meier, R., P. Hildebrand, M. Thumshirn, C. Albrecht, B. Studer, K. Gyr, and C. Beglinger. Effect of loxiglumide, a cholecystokinin antagonist, on pancreatic polypeptide release in humans. Gastroenterology 99: 1757-1762, 1990.
32. Meyer, B. M., B. A. Werth, C. Beglinger, P. Hildebrand, J. B. Jansen, D. Zach, L. C. Rovati, and G. A. Stalder. Role of cholecystokinin in regulation of gastrointestinal motor functions. Lancet 2: 12-15, 1989.
33. Miller, L. J., J. R. Malagelada, W. F. Taylor, and V. W. L. Go. Intestinal control of human postprandial gastric function. The role of components of jejuno-ileal chyme in regulating gastric secretion and gastric emptying. Gastroenterology 80: 763-769, 1981.
34. Moran, T. H., P. J. Ameglio, G. J. Schwartz, and P. R. McHugh. Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK. Am. J. Physiol. 262 (Regulatory Integrative Comp. Physiol. 31): R46-R50, 1992.
35. Moran, T. H., L. F. Katz, C. R. Plata-Salaman, and G. J. Schwartz. Disordered food intake and obesity in rats lacking cholecystokinin A receptors. Am. J. Physiol. 274 (Regulatory Integrative Comp. Physiol. 43): R618-R625, 1998.
36. Moran, T. H., and P. R. McHugh. Cholecystokinin suppresses food intake by inhibiting gastric emptying. Am. J. Physiol. 242 (Regulatory Integrative Comp. Physiol. 11): R491-R497, 1982.
37. Moran, T. H., T. K. Sawyer, D. H. Seeb, P. J. Ameglio, M. A. Lombard, and P. R. McHugh. Potent and sustained satiety actions of a cholecystokinin octapeptide analogue. Am. J. Clin. Nutr. 55: 286S-290S, 1992.
38. Muurahainen, N., H. R. Kissileff, A. J. Derogatis, and F. X. Pi-Sunyer. Effects of cholecystokinin-octapeptide (CCK-8) on food intake and gastric emptying in man. Physiol. Behav. 44: 645-649, 1988.
39. Muurahainen, N. E., H. R. Kissileff, J. Lachaussee, and F. X. Pi-Sunyer. Effect of a soup preload on reduction of food intake by cholecystokinin in humans. Am. J. Physiol. 260 (Regulatory Integrative Comp. Physiol. 29): R672-R680, 1991.
40. Read, N. W., A. McFarlane, R. I. Kinsman, and S. R. Bloom. Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and levels of neurotensin and enteroglucagon. Gastroenterology 86: 274-280, 1984.
41. Sachs, L. Angewandte Statistik. Berlin/Heidelberg: Springer, 1984.
42. Schmidt, W. E., W. Creutzfeldt, A. Schleser, A. R. Choudhury, R. Nustede, M. Höcker, R. Nitsche, H. Sostmann, L. C. Rovati, and U. R. Fölsch. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. Am. J. Physiol. 260 (Gastrointest. Liver Physiol. 23): G197-G206, 1991.
43. Spannagel, A. W., I. Nakano, T. Tawil, W. J. Chey, R. A. Liddle, and G. M. Green. Adaptation to fat markedly increases pancreatic secretory response to intraduodenal fat in rats. Am. J. Physiol. 270 (Gastrointest. Liver Physiol. 33): G128-G135, 1996.
44. Stacher, G., H. Bauer, and H. Steinringer. Cholecystokinin decreases appetite and activation evoked by stimuli arising from the preparation of a meal in man. Physiol. Behav. 23: 325-331, 1979.
45. Stacher, G., H. Steinringer, G. Schmiere, C. Schneider, and S. Winklehner. Cholecystokinin octapeptide decreases intake of solid food in man. Peptides 1: 133-136, 1982.
46. Weatherford, S. C., F. Y. Chiruzzo, and W. B. Laughton. Satiety induced by endogenous and exogenous cholecystokinin is mediated by CCK-A receptors in mice. Am. J. Physiol. 262 (Regulatory Integrative Comp. Physiol. 31): R574-R578, 1992.
47. Welch, I., K. Saunders, and N. W. Read. Effect of ileal and intravenous infusion of fat emulsion on feeding and satiety in human volunteers. Gastroenterology 89: 1293-1297, 1985.
48. Welch, I., C. P. Seeple, and N. W. Read. Comparison of the effect on satiety and eating behaviour of infusion of lipid into the different regions of the small intestine. Gut 29: 306-311, 1988.
49. Wolkowitz, O. M., B. Gertz, H. Weingartner, L. Beccaria, K. Thompson, and R. A. Liddle. Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist. Biol. Psychiatry 28: 169-173, 1990.
50. Yox, D. P., L. Brenner, and R. C. Ritter. CCK-receptor antagonists attenuate suppression of sham feeding by intestinal nutrients. Am. J. Physiol. 262 (Regulatory Integrative Comp. Physiol. 31): R554-R661, 1992.